Mohamed H Sayegh

This inventor holds 13 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 8 EPO patents. Top assignees: The Brigham and Women's Hospital, Inc., Children's Medical Center Corporation. Active years: 2001-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohamed H Sayegh. Retrieved from https://idiyas.com/inventor/mohamed-h-sayegh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 3)

% Patents Active = 76.9

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 7)

Average Co-Inventor Count = 2.3

ph-index = 9

Forward Citations = 136(Granted Patents)

Location History:

Boston, MA (US) (2011)
Westwood, MA (US) (2001 - 2018)

Company Filing History:

12 out of 1,428

The Brigham and Women's Hospital, Inc.

patents

1 out of 1,073

Children's Medical Center Corporation

patents

Years Active: 2001-2018

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9855342 - Targeting ABCB5 for cancer therapy (2018-01-02),

2. 9850305 - Methods of modulating immunity (2017-12-26),

3. 9561264 - Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof (2017-02-07),

4. 9266946 - Targeting ABCB5 for cancer therapy (2016-02-23),

5. 8697072 - Targeting ABCB5 for cancer therapy (2014-04-15),

6. 8507273 - Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof (2013-08-13),

7. 8425876 - Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7P15-21 and uses thereof (2013-04-23),

8. 8076091 - Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7P15-21 and uses thereof (2011-12-13),

9. 7928202 - Targeting ABCB5 for cancer therapy (2011-04-19),

10. 7883703 - Methods of modulating immunity (2011-02-08),

11. 7465554 - Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7p15-2 and uses thereof (2008-12-16),

12. 6846883 - Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof (2005-01-25),

13. 6218361 - Treatment of chronic allograft rejection with anti-angiogenic agents (2001-04-17),

Title: The Innovative Journey of Mohamed H Sayegh

Introduction: Mohamed H Sayegh, a distinguished inventor hailing from Westwood, MA (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Mohamed H Sayegh holds several patents in various technological domains, showcasing his versatility and ingenuity in creating novel solutions to complex problems.

Career Highlights: Throughout his illustrious career, Mohamed H Sayegh has demonstrated a keen ability to identify gaps in the market and develop innovative products that have revolutionized industries. His commitment to excellence and passion for innovation have earned him a reputation as a visionary inventor.

Collaborations: Mohamed H Sayegh has collaborated with leading tech companies, research institutions, and universities to further his research and bring his inventions to life. His collaborative spirit and dedication to pushing the boundaries of technology have led to numerous successful partnerships.

Conclusion: In conclusion, Mohamed H Sayegh's relentless pursuit of innovation and his remarkable contributions to the field of technology have solidified his position as a pioneering inventor. His work continues to inspire future generations of inventors to think outside the box and create solutions that shape the world we live in.

Profile summary based on public USPTO records.